Latonduine-1-Amino-Hydantoin Hybrid, Triazole-Fused Latonduine Schiff Bases and Their Metal Complexes: Synthesis, X-ray and Electron Diffraction, Molecular Docking Studies and Antiproliferative Activity
Creators
- 1. Institute of Inorganic Chemistry, University of Vienna, Währinger Strasse 42, A1090 Vienna, Austria
- 2. Institute of Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia
- 3. School of Pharmacy and Bioengineering, Keele University, Hornbeam Building, Staffordshire ST5 5BG, UK
Description
Abstract
A series of latonduine derivatives, namely 11-nitro-indolo[2,3-d]benzazepine-7-(1-amino-hydantoin) (B), triazole-fused indolo[2,3-d]benzazepine-based Schiff bases HL1 and HL2 and metal complexes [M(p-cymene)(HL1)Cl]Cl, where M = Ru (1), Os (2), and [Cu(HL2)Cl2] (3) were synthesized and characterized by spectroscopic techniques (UV–vis, 1H, 13C, 15N–1H HSQC NMR) and ESI mass spectrometry. The molecular structures of B and HL1 were confirmed by single-crystal X-ray diffraction, while that of 3 by electron diffraction of nanometer size crystalline sample. Molecular docking calculations of species B in the binding pocket of PIM-1 enzyme revealed that the 1-amino-hydantoin moiety is not involved in any hydrogen-bonding interactions, even though a good accommodation of the host molecule in the ATP binding pocket of the enzyme was found. The antiproliferative activity of organic compounds B, HL1 and HL2, as well as complexes 1–3 was investigated in lung adenocarcinoma A549, colon adenocarcinoma LS-174 and triple-negative breast adenocarcinoma MDA-MB-231 cells and normal human lung fibroblast cells MRC-5 by MTT assays; then, the results are discussed.
Keywords:
Notes
Files
Latonduine 1 Amino Hydantoin Hybrid, Triazole Fused.pdf
Files
(4.2 MB)
Name | Size | Download all |
---|---|---|
md5:f32c34e93366dbe280066d9fdd01f334
|
4.2 MB | Preview Download |
Additional details
Related works
- Is part of
- 2304-6740 (ISSN)
- Is supplemented by
- https://www.mdpi.com/article/10.3390/inorganics11010030/s1 (URL)
Funding
- Ministry of Education, Science and Technological Development, Republic of Serbia, Grant no. 451-03-68/2020-14/200043 (Institute of Oncology and Radiology of Serbia, Belgrade) 200043
- Ministry of Education, Science and Technological Development